Michael DeFiori

Coverage

Companies whose earnings calls Michael DeFiori asked questions on (from Lician's transcripts).

• ALTAltimmune, Inc.

Questions on earnings calls

1. ALT earnings call · Altimmune, Inc.Nov 12, 2026 · 2 questions
   • 29:21

     “Two for me, one on Proforma. I'm not sure if you disclosed in the past, but what placebo rate is it? And treatment effect did you assume for Proforma's fibrosis endpoint, and how does that compare with impact? And separately, for AUD, you know, now that the Phase II reclaimed…”

   • 33:01

     “Congrats on the progress. For AUD, could you remind us of the percentage of AUD patients who have obesity, diabetes, and MASH, and if there's any real-world evidence from, like, off the list?”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

Evercore ISI rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Michael DeFiori. We do not use licensed rating databases.